Salivary testosterone levels in male adolescents with cystic fibrosis

S. R. Boas, D. A. Cleary, Peter Lee, D. M. Orenstein

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose. Salivary testosterone concentrations have been used for monitoring testosterone levels in male adolescents and have been found to correlate closely with serum values. Data are lacking on such measurements in male adolescents with cystic fibrosis (CF), in which salivary gland abnormalities are commonly seen. Delayed sexual maturation occurs in many patients with CF, particularly those with severe disease. We examined the usefulness of salivary testosterone collection and measurement in male adolescents with CF. Methods. Forty boys with CF and 35 healthy control boys participated in the study. All boys were Tanner staged and had serum and salivary testosterone concentrations measured. Testosterone assays were performed using standard radioimmunoassay techniques. Results. The boys with CF were slightly older, lighter in body weight, and shorter. Serum and salivary testosterone concentrations were lower in the CF group than in the control group. A significant correlation was found between serum and salivary testosterone levels for boys with CF (r = .84) and for the control boys (r = .86). Mean salivary testosterone increased as age progressed and as Tanner stage advanced. Conclusions. These results demonstrate that salivary testosterone measurements correlate well with serum values in male adolescents with CF and can be used in the monitoring of pubertal status.

Original languageEnglish (US)
Pages (from-to)361-363
Number of pages3
JournalPediatrics
Volume97
Issue number3
StatePublished - 1996

Fingerprint

Cystic Fibrosis
Testosterone
Serum
Sexual Maturation
Salivary Glands
Radioimmunoassay
Body Weight
Control Groups

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Boas, S. R., Cleary, D. A., Lee, P., & Orenstein, D. M. (1996). Salivary testosterone levels in male adolescents with cystic fibrosis. Pediatrics, 97(3), 361-363.
Boas, S. R. ; Cleary, D. A. ; Lee, Peter ; Orenstein, D. M. / Salivary testosterone levels in male adolescents with cystic fibrosis. In: Pediatrics. 1996 ; Vol. 97, No. 3. pp. 361-363.
@article{d6a0afcc27df4a22b9d2e1a3fbd76f1c,
title = "Salivary testosterone levels in male adolescents with cystic fibrosis",
abstract = "Purpose. Salivary testosterone concentrations have been used for monitoring testosterone levels in male adolescents and have been found to correlate closely with serum values. Data are lacking on such measurements in male adolescents with cystic fibrosis (CF), in which salivary gland abnormalities are commonly seen. Delayed sexual maturation occurs in many patients with CF, particularly those with severe disease. We examined the usefulness of salivary testosterone collection and measurement in male adolescents with CF. Methods. Forty boys with CF and 35 healthy control boys participated in the study. All boys were Tanner staged and had serum and salivary testosterone concentrations measured. Testosterone assays were performed using standard radioimmunoassay techniques. Results. The boys with CF were slightly older, lighter in body weight, and shorter. Serum and salivary testosterone concentrations were lower in the CF group than in the control group. A significant correlation was found between serum and salivary testosterone levels for boys with CF (r = .84) and for the control boys (r = .86). Mean salivary testosterone increased as age progressed and as Tanner stage advanced. Conclusions. These results demonstrate that salivary testosterone measurements correlate well with serum values in male adolescents with CF and can be used in the monitoring of pubertal status.",
author = "Boas, {S. R.} and Cleary, {D. A.} and Peter Lee and Orenstein, {D. M.}",
year = "1996",
language = "English (US)",
volume = "97",
pages = "361--363",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

Boas, SR, Cleary, DA, Lee, P & Orenstein, DM 1996, 'Salivary testosterone levels in male adolescents with cystic fibrosis', Pediatrics, vol. 97, no. 3, pp. 361-363.

Salivary testosterone levels in male adolescents with cystic fibrosis. / Boas, S. R.; Cleary, D. A.; Lee, Peter; Orenstein, D. M.

In: Pediatrics, Vol. 97, No. 3, 1996, p. 361-363.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Salivary testosterone levels in male adolescents with cystic fibrosis

AU - Boas, S. R.

AU - Cleary, D. A.

AU - Lee, Peter

AU - Orenstein, D. M.

PY - 1996

Y1 - 1996

N2 - Purpose. Salivary testosterone concentrations have been used for monitoring testosterone levels in male adolescents and have been found to correlate closely with serum values. Data are lacking on such measurements in male adolescents with cystic fibrosis (CF), in which salivary gland abnormalities are commonly seen. Delayed sexual maturation occurs in many patients with CF, particularly those with severe disease. We examined the usefulness of salivary testosterone collection and measurement in male adolescents with CF. Methods. Forty boys with CF and 35 healthy control boys participated in the study. All boys were Tanner staged and had serum and salivary testosterone concentrations measured. Testosterone assays were performed using standard radioimmunoassay techniques. Results. The boys with CF were slightly older, lighter in body weight, and shorter. Serum and salivary testosterone concentrations were lower in the CF group than in the control group. A significant correlation was found between serum and salivary testosterone levels for boys with CF (r = .84) and for the control boys (r = .86). Mean salivary testosterone increased as age progressed and as Tanner stage advanced. Conclusions. These results demonstrate that salivary testosterone measurements correlate well with serum values in male adolescents with CF and can be used in the monitoring of pubertal status.

AB - Purpose. Salivary testosterone concentrations have been used for monitoring testosterone levels in male adolescents and have been found to correlate closely with serum values. Data are lacking on such measurements in male adolescents with cystic fibrosis (CF), in which salivary gland abnormalities are commonly seen. Delayed sexual maturation occurs in many patients with CF, particularly those with severe disease. We examined the usefulness of salivary testosterone collection and measurement in male adolescents with CF. Methods. Forty boys with CF and 35 healthy control boys participated in the study. All boys were Tanner staged and had serum and salivary testosterone concentrations measured. Testosterone assays were performed using standard radioimmunoassay techniques. Results. The boys with CF were slightly older, lighter in body weight, and shorter. Serum and salivary testosterone concentrations were lower in the CF group than in the control group. A significant correlation was found between serum and salivary testosterone levels for boys with CF (r = .84) and for the control boys (r = .86). Mean salivary testosterone increased as age progressed and as Tanner stage advanced. Conclusions. These results demonstrate that salivary testosterone measurements correlate well with serum values in male adolescents with CF and can be used in the monitoring of pubertal status.

UR - http://www.scopus.com/inward/record.url?scp=0029926401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029926401&partnerID=8YFLogxK

M3 - Article

C2 - 8604271

AN - SCOPUS:0029926401

VL - 97

SP - 361

EP - 363

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -